SCHEMBL6358657

SCHEMBL6358657

COC(=O)c1ccc(COc2cccc(C(=O)Nc3ccc(Br)cc3C(=O)O)c2)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C2 P52895 3/20 0.72
AKR1C1 Q04828 3/20 0.72
SMPD1 P17405 4/20 0.57
AKR1C4 P17516 1/20 0.57
AKR1C3 P42330 1/20 0.57
HDAC1 Q13547 1/20 0.53
HDAC8 Q9BY41 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
MAOA P21397 1/20 0.53
MAOB P27338 1/20 0.53
NR1H4 Q96RI1 2/20 0.53
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
MAPT P10636 2/20 0.52
ABL1 P00519 1/20 0.52
TSHR P16473 1/20 0.52
RIN1 Q13671 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
NPC1 O15118 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4209179 0.90 AKR1C2 (0.56) AKR1C2AKR1C1AKR1C4AKR1C3MAOB
SCHEMBL6352019 0.90 AKR1C2 (0.78) AKR1C2AKR1C1SMPD1AKR1C4AKR1C3
SCHEMBL6357045 0.87 AKR1C2 (0.74) AKR1C2AKR1C1SMPD1AKR1C4AKR1C3
SCHEMBL6353185 0.86 AKR1C2 (0.72) AKR1C2AKR1C1SMPD1AKR1C4AKR1C3
SCHEMBL6360447 0.84 AKR1C2 (0.82) AKR1C2AKR1C1AKR1C4AKR1C3NR1H4
SCHEMBL6350825 0.84 AKR1C2 (1.00) AKR1C2AKR1C1AKR1C4AKR1C3NR1H4
SCHEMBL6359823 0.83 AKR1C2 (0.78) AKR1C2AKR1C1AKR1C4AKR1C3MEN1
SCHEMBL6352870 0.83 AKR1C2 (0.70) AKR1C2AKR1C1SMPD1AKR1C4AKR1C3
SCHEMBL6352473 0.83 AKR1C2 (0.77) AKR1C2AKR1C1AKR1C4AKR1C3MEN1
SCHEMBL6350824 0.82 KCNK2 (0.62) AKR1C2AKR1C1AKR1C4AKR1C3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed
WO-2004018414-A2 ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 AKR1C2 3012/4885AKR1C1 2615/4885SMPD1 63/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.